This panel is not meant to be complete, but can be used as a starting point for GI. Locally used antibodies can always be added to the panel. We want to cover the most used antibodies in our panels and, where possible, add information/ papers on prefered antibodies over others. Please feel free to make remarks/ observations and let Sakura know.
Tumor of unknown origin -> (upper) GI | |
Cytokeratin-Pan | + |
CK7 | + |
CK20 | _ |
CDX2 | + |
Gastrointestinal:
Diagnosis | Commonly used biomarkers | |||||
Esophageal neoplasms |
CK7 | CK20 | CDX2 | MLH1 | MSH2 | MSH6 |
PMS2 | PD-L1 | MUC2 | p53 | p40 | CK5/6 | |
CK14 | p16 | |||||
Gastric neoplasms |
CK7 | CK20 | CDX2 | MLH1 | MSH2 | MSH6 |
PMS2 | MUC1 | MUC2 | MUC5AC | p53 | Ki67 | |
CD34 | ASMA | S100 | HER2 | Desmin | PD-L1 | |
CD20 | CD79a | PAX5 | CD5 | CD10 | CD23 | |
Hepatocellular neoplasms | HepPar-1 | Arginase-1 | CEA | CD10 | CK7 | CK19 |
CK20 | CDX2 | Glypican-3 | SALL4 | CD34 | beta-Catenin | |
AFP | EMA | CK17 | ||||
Pancreatic neoplasms |
CK7 | CK20 | CDX2 | MLH1 | MSH2 | MSH6 |
PMS2 | CK19 | Chromogranin | Synaptophysin | CD56 | Ki67 | |
CK8/18 | EMA | CEA | SMAD4 | beta-Catenin | MUC1 | |
MUC2 | MUC5AC | |||||
Small intestine neoplasms |
CK20 | CDX2 | CK7 | MLH1 | MSH2 | MSH6 |
PMS2 | ||||||
Colorectal/ anal neoplasms |
CK20 | CDX2 | CK7 | MUC2 | MLH1 | MSH2 |
MSH6 | PMS2 | SATB2 | p53 | Cadherin 17 | CEA | |
CK 5/6 | CK14 | p40 | BRAFv600E | HER2 | beta-Catenin | |
GCDFP-15 | p16 | |||||
Neuroendocrine neoplasms | INSM1 | Chromogranin | Synaptophysin | CD56 | Ki67 | Gastrin |
GIST | DOG1 | CD117 | CD34 | ASMA | S100 | Desmin |
Immune mediated/ autoimmune | CD3 | PD-L1 | IgG | IgG4 | CD117 | |
Infectious |
CMV | H. pylori | HSV1 | HSV2 | EBER | p16/HPV |
Treponema pallidum | ||||||
The bolded are the most used biomarkers |
Comments
0 comments
Please sign in to leave a comment.